• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Malignant proliferating trichilemmal tumours: an histopathological and immunohistochemical study of three cases with DNA ploidy and morphometric evaluation.

作者信息

Herrero J, Monteagudo C, Ruiz A, Llombart-Bosch A

机构信息

Department of Pathology, University of Valencia, Spain.

出版信息

Histopathology. 1998 Dec;33(6):542-6. doi: 10.1046/j.1365-2559.1998.00549.x.

DOI:10.1046/j.1365-2559.1998.00549.x
PMID:9870149
Abstract

AIMS

Malignant proliferating trichilemmal tumours (MPTT) are rare neoplasms capable of tissue invasion and metastasis, the diagnosis of which is based essentially on histological features. In difficult cases, however, evaluation of additional parameters may be needed to diagnose malignancy.

METHODS AND RESULTS

We report three cases of MPTT in which, in addition to the histological features, we have determined the DNA ploidy, nuclear area and proliferative fraction. CD34 immunoreactivity has also been tested. Two cases were aneuploid, and one diploid with increased proliferating index. PCNA immunostaining labelled 40% and 80% of tumour cells in aneuploid tumours and 30% of the diploid neoplasm. In all cases, nuclear area was consistent with large pleomorphic tumour cells. No CD34 immunostaining was detected.

CONCLUSIONS

Aneuploidy is common in MPTT, particularly in tumours with a high proliferative fraction. Loss of CD34 immunoreactivity is an additional feature of potential, though limited, value. Therefore, evaluation of the DNA content, proliferation markers and CD34 immunostaining may be helpful in the diagnosis of MPTT.

摘要

相似文献

1
Malignant proliferating trichilemmal tumours: an histopathological and immunohistochemical study of three cases with DNA ploidy and morphometric evaluation.
Histopathology. 1998 Dec;33(6):542-6. doi: 10.1046/j.1365-2559.1998.00549.x.
2
Malignant proliferating trichilemmal tumors with CD34 expression.伴有CD34表达的恶性增殖性外毛根鞘瘤
J Med Assoc Thai. 2010 Nov;93 Suppl 6:S28-34.
3
Cellular proliferation and nuclear ploidy assessments augment established prognostic factors in predicting malignancy in testicular Leydig cell tumours.细胞增殖和核倍性评估增强了既定预后因素在预测睾丸间质细胞瘤恶性程度方面的作用。
Histopathology. 1998 Oct;33(4):361-8. doi: 10.1046/j.1365-2559.1998.00484.x.
4
Malignant proliferating trichilemmal tumor involving the sinuses.累及鼻窦的恶性增殖性外毛根鞘瘤。
Ear Nose Throat J. 2011 Jul;90(7):E5-8. doi: 10.1177/014556131109000719.
5
A rippled-pattern trichoblastoma: an immunohistochemical study.波纹状毛囊母细胞瘤:一项免疫组织化学研究。
J Cutan Pathol. 2000 Oct;27(9):460-5. doi: 10.1034/j.1600-0560.2000.027009460.x.
6
Trichoepithelioma with an adjacent basal cell carcinoma, transformation or collision?伴有相邻基底细胞癌的毛发上皮瘤,是转化还是碰撞?
J Am Acad Dermatol. 1997 Aug;37(2 Pt 2):343-5.
7
Two Cases of Malignant Proliferating Trichilemmal Tumor (MPTT) and Review of Literature.两例恶性增殖性毛根鞘瘤(MPTT)及文献复习。
R I Med J (2013). 2022 Feb 1;105(1):12-16.
8
Differential diagnosis of basal cell carcinoma and benign tumors of cutaneous appendages originating from hair follicles by using CD34.利用CD34对基底细胞癌和起源于毛囊的皮肤附属器良性肿瘤进行鉴别诊断。
Asian Pac J Cancer Prev. 2010;11(6):1615-9.
9
The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases.倍性和增殖在膀胱肿瘤临床及生物学评估中的意义:100例未经治疗病例的研究
Br J Urol. 1982 Apr;54(2):130-5. doi: 10.1111/j.1464-410x.1982.tb13536.x.
10
Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.卵巢癌的肿瘤倍体、形态测定、组织学分级及临床特征:相互关系
Anal Cell Pathol. 1991 Sep;3(5):261-71.

引用本文的文献

1
A Rare Case of a Malignant Proliferating Trichilemmal Tumor: A Molecular Study Harboring Potential Therapeutic Significance and a Review of Literature.恶性增殖性外毛根鞘瘤1例罕见病例:一项具有潜在治疗意义的分子研究及文献复习
Dermatopathology (Basel). 2024 Dec 10;11(4):354-363. doi: 10.3390/dermatopathology11040038.
2
Proliferating Pilar Tumor of the Cheek Misdiagnosed as Squamous Cell Carcinoma.误诊为鳞状细胞癌的颊部增生性毛发上皮瘤
Indian J Dermatol. 2022 Mar-Apr;67(2):207. doi: 10.4103/ijd.ijd_58_21.
3
Malignant proliferating trichilemmal tumor of the scalp: report of 4 cases and a short review of the literature.
头皮恶性增殖性外毛根鞘瘤:4例报告并文献复习
Case Reports Plast Surg Hand Surg. 2022 May 23;9(1):158-164. doi: 10.1080/23320885.2022.2077208. eCollection 2022.
4
Malignant Proliferating Trichilemmal Tumor: A Subtle Presentation in an African American Woman and Review of Immunohistochemical Markers for This Rare Condition.恶性增殖性外毛根鞘瘤:一名非裔美国女性的隐匿表现及对这种罕见病症免疫组化标志物的综述
Cureus. 2021 Aug 18;13(8):e17289. doi: 10.7759/cureus.17289. eCollection 2021 Aug.
5
Abnormalities and MMR Preservation in 5 Cases of Proliferating Trichilemmal Tumours.5例增殖性外毛根鞘瘤的异常表现及错配修复状态
Dermatopathology (Basel). 2021 May 25;8(2):147-158. doi: 10.3390/dermatopathology8020021.
6
Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibition.转移性恶性增殖性毛囊瘤的基因组图谱及其对PI3K抑制的反应。
NPJ Precis Oncol. 2019 Feb 15;3:5. doi: 10.1038/s41698-019-0077-2. eCollection 2019.
7
Metastatic trichilemmal carcinoma in a patient with breast cancer.一名乳腺癌患者发生的转移性外毛根鞘癌。
BMJ Case Rep. 2016 Nov 21;2016:bcr2016217661. doi: 10.1136/bcr-2016-217661.
8
A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor.一种罕见的皮肤附属器肿瘤:恶性增生性外毛根鞘瘤。
Case Rep Med. 2015;2015:742920. doi: 10.1155/2015/742920. Epub 2015 May 4.
9
Malignant proliferating trichilemmal tumour presenting early in life: an uncommon feature.恶性增生性外毛根鞘瘤在生命早期出现:一种不常见的特征。
J Cutan Aesthet Surg. 2011 Jan;4(1):51-5. doi: 10.4103/0974-2077.79196.
10
Trichilemmal carcinoma of the upper eyelid: a case report.上睑外毛根鞘癌:一例报告
Korean J Ophthalmol. 2009 Dec;23(4):301-5. doi: 10.3341/kjo.2009.23.4.301. Epub 2009 Dec 4.